1. Chronic Obstructive Pulmonary Disease and Heart Failure
- Author
-
Felipe Villar Álvarez, Javier de Miguel Díez, and Manuel Méndez Bailón
- Subjects
COPD ,medicine.medical_specialty ,business.industry ,medicine.drug_class ,Clinical course ,Pulmonary disease ,General Medicine ,medicine.disease ,respiratory tract diseases ,Pulmonary function testing ,Heart failure ,Internal medicine ,Natriuretic peptide ,Cardiology ,Medicine ,In patient ,business ,Heart Function Tests - Abstract
Chronic obstructive pulmonary disease (COPD) is commonly associated with heart failure. Individuals with COPD have a 4.5-fold greater risk of developing heart failure than those without. The sensitivity and specificity of clinical judgment in the diagnosis of heart failure in patients with COPD can be enhanced by biological markers such as B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide. Correct interpretation of imaging results (mainly echocardiographic findings) and lung function tests can also help establish the co-occurrence of both conditions. There is little evidence on the management of patients with COPD and heart failure, although treatment of COPD undeniably affects the clinical course of patients with heart failure and viceversa.
- Published
- 2009